Most floaters are benign and fade with time (your brain learns to ignore them)
Floaters & PVD
Posterior vitreous detachment—the gel in your eye shrinks and pulls away, leaving clumps that cast shadows.
Red Flags — Seek Care Immediately
- Sudden onset of many new floaters (like a shaken snow globe)
- Flashes of light in peripheral vision (especially in dark)
- Curtain or shadow creeping across vision from any side
- Vision loss or distortion (straight lines look wavy)
What You Need to Know
The essential facts before we get into treatments.
No drop or supplement reliably dissolves floaters, but some oral formulations show modest symptomatic benefit
YAG laser works for discrete Weiss rings (single large ring), not diffuse clouds
Sudden shower + flashes + curtain = retinal tear (go to ER immediately)
What Actually Works (Evidence-Based)
These treatments have RCT data or major society guideline backing (AAO, TFOS, AREDS).
Low-Risk Adjunctive Options
These oral/topical interventions have early human data for symptomatic floater relief. They are investigational, not FDA-approved for floaters, and not replacements for observation or procedures.
VitroCap N
Protocol: L-lysine 125 mg, Vit C 40 mg, Vitis vinifera extract 26.3 mg, zinc 5 mg, Citrus aurantium 100 mg
Evidence: Double-blind RCT (n=61, 6 months): P<0.001 reduction in subjective discomfort and objective opacity area; contrast sensitivity P=0.047.
Closest match: VitroCap N supplement
Proteolytic enzyme mix
Protocol: 190 mg bromelain + 95 mg papain + 95 mg ficin per capsule, 1–3 capsules/day
Evidence: Prospective cohort (n=280, 3 months): 65.5–75.5% SVO reduction vs placebo; dose-dependent response.
Closest match: Closest option: enteric-coated bromelain 190 mg + papain 95 mg with ficin if available
Curcumin-based supplement (post-YAG)
Protocol: Curcumin-based formulation after Nd:YAG capsulotomy
Evidence: Pilot study (Malandrini et al., 2025): Significant reduction in symptomatic vitreous floaters and foreign-body sensation; improved visual quality.
Closest match: Curcumin supplement with piperine/bioenhancers
Low-dose atropine 0.01% drops
Protocol: 1 drop/day, off-label
Evidence: Small prospective cohort (n=44, ASRS 2025 pilot): 59% satisfaction after 1 week; pupillary dilation may reduce floater salience.
Closest match: Compounded 0.01% atropine drops
These are low-risk oral/topical options with early human data. They are investigational, not FDA-approved for floaters, and should be considered adjuncts rather than replacements for observation or procedural treatment.
Products with Data Behind Them
These match the adjunctive options and treatments above — we only list products with clinical evidence for their ingredients. Affiliate links support the site at no cost to you.
VitroCap N
Ankamah et al., TVST 2021;10(12):19. Double-blind RCT in symptomatic floaters: P<0.001 reduction in discomfort and objective opacity area; contrast sensitivity P=0.047. [View study]
- Serving:
- 1 capsule
- Key:
- L-lysine 125 mg, Vitamin C 40 mg, Vitis vinifera extract 26.3 mg...
Pros
- Closest match to study protocol
- Double-blind RCT data
- Objective opacity reduction outcome
Cons
- Small trial
- Not FDA-approved for floaters
- Single-center study
Affiliate link — we may earn a commission
Bromelain + Papain + Ficin Enzyme Blend
Takeuchi et al., Appl Sci 2020;10(17):5901. Prospective cohort, n=280, 3 months: 65.5–75.5% symptomatic vitreous opacity reduction vs placebo. [View study]
- Serving:
- 1 capsule
- Key:
- Bromelain 190 mg, Papain 95 mg, Ficin 95 mg
Pros
- Matches study dosing
- Largest human cohort in this space
- Dose-dependent response
Cons
- No exact branded product match
- Ficin is rare in commercial blends
- Open-label design
Affiliate link — we may earn a commission
Curcumin + Piperine Bioavailable Supplement
Malandrini et al., Vision 2025. Pilot study: curcumin-based supplement after Nd:YAG capsulotomy reduced symptomatic floaters and foreign-body sensation. [View study]
- Serving:
- 1 capsule
- Key:
- Curcumin 1500 mg, Piperine 5 mg
Pros
- Widely available
- Bioavailable form
- Pilot data in post-YAG population
Cons
- Pilot study only
- Post-procedure population only
- Not proven for de novo floaters
Affiliate link — we may earn a commission
Compounded Atropine 0.01% Drops
Du J, Sabbagh O, Do BK, et al. J Vitreoretin Dis 2025;9(6):831-835. Prospective cohort, n=44, 1 week: 59% satisfaction among completers; pupillary dilation is proposed mechanism. [View study]
- Serving:
- 1 drop
- Key:
- Atropine sulfate 0.01%
Pros
- Low concentration profile
- Symptomatic relief pathway
Cons
- Off-label use
- Short study duration
- Requires compounding pharmacy
Affiliate link — we may earn a commission
What Doesn't Work (Save Your Money)
These are the ones I get asked about most, usually by someone who's already bought the bottle. I wish the answer were better.
Castor oil drops (cannot reach vitreous; corneal toxicity risk)
Generic 'floater' supplements without specific formulation data
Eye exercises / Bates method (cannot change axial length)
Collagen or hyaluronic acid supplements for floater reduction
When to See an Eye Doctor
New floaters with flashes? Go today. Sudden shower of floaters + curtain in vision? ER now—retinal detachment can cause permanent vision loss in hours. Routine floaters that are stable for months? Annual dilated exam is fine.
Helpful Guides
Author and Review Information
Medical information reviewed by NP Bate, Ed.S. • Last reviewed: 2026-08-08 • Not a substitute for professional care.